Public health impact and harm reduction implications of xylazine-involved overdoses: a narrative review

Xylazine, an α2-adrenoceptor agonist sedative commonly used in veterinary medicine, is not approved for human use. Nevertheless, xylazine-involved overdose rates have surged in recent years, fueled by an incre...
Source: Harm Reduction Journal - Category: Drugs & Pharmacology Authors: Tags: Review Source Type: research